Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

We aimed to examine, for the first time, the effect of cannabidiol (CBD) and palmitoylethanolamide (PEA) on the permeability of the human gastrointestinal tract in vitro, ex vivo, and in vivo.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Inflamm. Bowel Dis.

Title: Inflammatory bowel diseases

Publisher: Oxford University Press (OUP)

ISSN (Electronic): 1536-4844

ISSN (Print): 1078-0998

Publication date (Electronic): May 04 2019

Volume: 25

Issue: 6

Affiliations

[1 ] Division of Medical Sciences and Graduate Entry Medicine, University of Nottingham, Derby, United Kingdom.

[2 ] Faculty of Science, University of Nottingham, Nottingham, United Kingdom.

Article

Publisher Item ID: 5341970

DOI: 10.1093/ibd/izz017

PubMed ID: 31054246

SO-VID: dd527426-f3e6-4aea-9400-87c232b59350

History

Keywords: intestinal,permeability,human,cannabidiol,palmitoylethanolamide

Data availability:

Keywords: intestinal, permeability, human, cannabidiol, palmitoylethanolamide

Comments

Comment on this article

scite_

Cited by 36

See all cited by